To compare the frequency of severe hypoglycemia events for 5 dosing algorithms of Lantus®,
each of varying intensity and defined by their end-of -study target for self monitored plasma
glucose(SMPG), in patients with Type 2 diabetes mellitus, with inadequate glycemic control
(A1C greater than or equal to 7.0%) on oral antidiabetic drug therapy(OAD).